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Characterization of α‑Synuclein Multimer Stoichiometry in Complex
Biological Samples by Electrophoresis
Bryan A. Killinger* and Anna Moszczynska
Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259
Mack Avenue, Detroit, Michigan 48201, United States
ABSTRACT: The aberrant aggregation of α-synuclein in the brain is
a hallmark of Parkinson’s disease (PD). In vivo soluble α-synuclein
occurs as a monomer and several multimers, the latter of which may
be important for the biological function of α-synuclein. Currently,
there is a lack of reproducible methods to compare α-synuclein
multimer abundance between complex biological samples. Here we
developed a method, termed “multimer-PAGE,” that combines in-gel
chemical cross-linking with several common electrophoretic
techniques to measure the stoichiometry of soluble α-synuclein
multimers in brain tissue lysates. Results show that soluble α-
synuclein from the rat brain exists as several high molecular weight
species of approximately 56 kDa (αS56), 80 kDa (αS80), and 100
kDa (αS100) that comigrate with endogenous lipids, detergents, and/or micelles during blue native gel electrophoresis (BN-
PAGE). Co-extraction of endogenous lipids with α-synuclein was essential for the detection of soluble α-synuclein multimers.
Homogenization of brain tissue in small buﬀer volumes (>50 mg tissue per 1 mL buﬀer) increased relative lipid extraction and
subsequently resulted in abundant soluble multimer detection via multimer-PAGE. α-Synuclein multimers captured by directly
cross-linking soluble lysates resembled those observed following multimer-PAGE. The ratio of multimer (αS80) to monomer
(αS17) increased linearly with protein input into multimer-PAGE, suggesting to some extent, multimers were also formed during
electrophoresis. Overall, soluble α-synuclein maintains lipid interactions following tissue disruption and readily forms multimers
when this lipid−protein complex is preserved. Once the multimer-PAGE technique was validated, relative stoichiometric
comparisons could be conducted simultaneously between 14 biological samples. Multimer-PAGE provides a simple inexpensive
biochemical technique to study the molecular factors inﬂuencing α-synuclein multimerization.
Parkinson’s disease (PD) is a neurodegenerative diseasecharacterized by the formation of proteinaceous inclusions,
termed “Lewy bodies” that contain large amounts of α-synuclein,
a small cytosolic protein for which the biological function is still
unclear.1,2 In vivo α-synuclein occurs as a variety of multimers
including a dimer, tetramer, and octomer which appear to be
biologically important and possibly resistant to toxic aggrega-
tion.3−5 New therapeutic strategies for treating PD may involve
the use of drugs to stabilize soluble multimeric α-synuclein to
prevent the formation of higher order soluble toxic multimers.6
Soluble monomeric α-synuclein is an intrinsically disordered
protein and behaves like a larger protein of ∼50−60 kDa when
assessed using a number of techniques including size-exclusion
chromatography and blue native gel electrophoresis (BN-
PAGE).4 The unusual behavior of α-synuclein makes the
separation of native multimers from the monomer, according
to mass, particularly challenging. Chemical cross-linking can be
used to preserve α-synuclein multimers allowing their separation
from the monomer by traditional sodium dodecylsulfate
polyacrylamide electrophoresis (SDS-PAGE).3,6,7 α-Synuclein
multimerizes upon binding to phospholipid membranes, but it
remains unclear whether free soluble α-synuclein can form stable
soluble multimers. Upon binding to phospholipid membranes α-
synuclein adopts deﬁned secondary structure and subsequently
multimerize.2,8 Although the interaction between α-synuclein
with phospholipid membranes is intimately involved in the
multimerization process and biological function of α-synuclein,
the molecular details of this interaction remain unclear.
Here, we developed a new technique, termed “multimer-
PAGE,” to quantify the multimerization of α-synuclein in
complex biological samples. Using this technique it is possible to
compare the ratio of α-synuclein multimers between 14 brain
tissue samples without the need for specialized equipment.
■ METHODS
Animals. Twenty adult male Sprague−Dawley (SD) rats
(250−350g) were pair housed in polycarbonate cages at
approximately 70 °F. Rats were euthanized via live decapitation.
Following euthanasia, the brain was removed and dissected on
ice. All collected brain tissue was placed on dry ice and frozen at
−80 °C until assayed. All procedures were conducted in
accordance with the Wayne State University institutional care
and use committee approved protocol no. A3310-01.
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Sample Preparation. All procedures were conducted on ice
and in a cold room. Frozen brain tissue samples weighing
approximately 25−200 mg were homogenized in 1 mL of 1×
BN-PAGE sample buﬀer (Invitrogen, Waltham, MA) for native
separation or phosphate buﬀered saline pH 7.4 (PBS) for in-
solution cross-linking experiments. All solutions contained
EDTA free protease inhibitor cocktail (Sigma-Aldrich, St.
Louis, MO). Tissue was disrupted using 30 strokes in a 7 mL
dounce homogenizer. Following homogenization, samples were
brieﬂy vortexed and incubated on ice for 30 min. For some
experiments, 0.5% m/vol NP40 (Boston Bioproducts, St.
Ashland, MA) or 1% m/vol digitonin (Sigma) was added to
the lysate prior to the 30 min incubation on ice. The sample was
then centrifuged at 18 000g for 30 min. Following centrifugation
the supernatant (S1) was carefully transferred to a prechilled 1.5
mL eppendorf tube. To determine protein concentration of the
sample, 8 μL of the S1 was transferred to a separate eppendorf
tube containing 2 μL of 10% m/vol SDS, mixed well, and
incubated at room temperature for 10 min. This delipidated
sample was then used to determine the protein content using a
bicinchoninic acid assay (BCA assay, Thermoﬁsher, Waltham,
MA). Samples were diluted to a ﬁnal concentration of 0.1−4 mg
protein/mL, depending on the experiment. The insoluble pellet
(P1) was resuspended in 1.5 mL of RIPA buﬀer (10 mM Tris-
HCl pH 8.0, 1% vol/vol Triton X-100, 0.1% m/vol sodium
dodecyl sulfate, and 140 mM NaCl), mixed thoroughly, and
incubated on ice for 1 h. The P1 sample was then centrifuged at
18 000g for 30 min at 4 °C, and the supernatant retained (S2).
The S2 was then processed for lipid and protein quantiﬁcation. α-
Synuclein was puriﬁed as previously described.9 Relative purity of
α-synuclein was determined by SDS-PAGE and subsequent
Coomassie Blue G-250 staining. The lyophilized puriﬁed α-
synuclein was dissolved in 1× BN-PAGE sample buﬀer for native
separation or PBS for in-sample cross-linking experiments to a
ﬁnal concentration of 5 mg protein/mL.
Lipid and Protein Isolation. Bulk lipid extraction was
performed essentially as previously described.10 Brieﬂy, 20 mL of
a chloroform and methanol mixture (2:1) was added to 1 g of rat
brain tissue. The tissue was homogenized via sonication for 2
min. The homogenate was vortexed well, 4 mL of PBS added,
and the sample vortexed again. The sample was then allowed to
sit for 5 min to allow the solution to separate into two phases.
The organic phase containing the puriﬁed lipids at the bottom of
the tube was carefully removed and dried under vacuum using a
Centrivap DNA Concentrator (Labconco, Kansas City, MO).
The puriﬁed lipids were then resuspended in 200 μL of 1× BN-
PAGE sample buﬀer containing 10% vol/vol NP40, bath
sonicated for 30 min, and centrifuged at 18 000g to remove
any insoluble lipids not incorporated into the NP40 micelles.
Isolated lipids were used within 24 h to avoid excessive lipid
oxidation. Extracted brain lipids were used for generating a lipid
standard for total lipid determination and to generate mixed
micelles only (Figure 2A,D).
To extract lipid and proteins from individual lysates we ﬁrst
diluted the samples to 2 mg protein/mL using the appropriate
buﬀer in a 1.5 mL eppendorf tube. The dilution was conducted to
yield a ﬁnal sample volume of 150 μL. Then 600 μL of methanol
and 150 μL of chloroform were added to each sample. Samples
were mixed well, 450 μL of dH20 added to each sample, and
mixed well again. Samples were then centrifuged at 14 000g for 5
min. The upper aqueous phase was then carefully discarded,
making sure not to disturb the precipitated proteins between the
lower and upper phase. A volume of 450 μL ofmethanol was then
added to each sample, vortexed, and centrifuged at 14 000g for 5
min. The methanol−chloroform mixture contained the lipids
and precipitated proteins were found in the pellet. The extracted
lipids from individual samples were used to quantify the amount
of soluble lipids (Figure 2D). The precipitated proteins from
individual samples were used for mixed micelles experiments
(Figure 2A).
The precipitated proteins (300 μg) were dissolved in 100 μL of
1× BN-PAGE sample buﬀer containing either 0.5% NP40 or
0.5% NP40 brain lipid mixture. Samples were mixed thoroughly,
allowed to sit on ice for 30 min, and mixed thoroughly again. All
samples were then centrifuged 18 000g for 30 min to remove any
remaining insoluble lipids or proteins. Protein content of each
mixture was then determined using BCA assay.
BN-PAGE. Procedures were conducted as previously
described.11 Brieﬂy, linear gradient 2.8−13%T and nongradient
6%T gels were used for all BN-PAGE separations. All gradient
gels were poured by hand using a linear gradient former built as
previously described.12 A 2.8%T gel was used for the sample
wells. The 0−0.5% m/v Coomassie Blue G-250 (Sigma-Aldrich,
St. Louis, MO) was added to all samples immediately prior to
electrophoresis and 4−50 μg of brain tissue lysate protein or 50−
200 ng of puriﬁed α-synuclein were loaded into each sample well
of the BN-PAGE gel. Either native page marker (Invitrogen) or 1
μg of bovine serum albumin (BSA, Santa Cruz Biotechnology,
Dallas, TX) diluted in 1× BN-PAGE buﬀer was used as a protein
standard. Electrophoresis was conducted using running buﬀer
(100 mM bis-tris, 100 mM tricine) containing either 0.001% (for
nondetergent samples) or 0.01% (for detergent samples) G-250
at 100 V until the samples entered the gel and then 180 V for
approximately 3 h (until the dye front reached the end of the gel)
at 4 °C. When detergent samples were resolved, the running
buﬀer containing 0.01% G-250 was replaced by the running
buﬀer containing 0.001% G-250, approximately halfway through
the run. 6%T BN-PAGE gels were run under the same conditions
but stopped once samples had migrated about 2 cm into the
resolving gel. Once electrophoresis was complete the lanes of the
gel were either excised for 2D electrophoresis or electroblotted
onto methanol activated polyvinylidene ﬂuoride (PVDF)
membranes. Electroblotting of BN-PAGE gels was performed
at 20 V for 3 h at 4 °C using the BN-PAGE running buﬀer.
Following electroblotting, PVDF membranes were ﬁxed for 20
min in 10% acetic acid, rinsed with ultrapure water, and then
dried.
In-Gel Cross-Linking. Excised gel pieces were washed with
PBS three times for 10 min at 4 °C to remove excess bis-tris and
6-aminocaproic acid because could compete with cross-linking
reactions. Gel lanes were then incubated for 5−30 min at 4 °C in
PBS containing either 1% paraformaldehyde (PFA), 1%
glutaradehyde, 0.1−2 mM Dithiobis (succinimidylpropionate)
(DSP, ThermoFisher Scientiﬁc, Waltham, MA), 0.1−2 mM 3,3′-
dithiobis (sulfosuccinimidyl propionate) (DTSSP, Thermoﬁsher
Scientiﬁc), or 0.1−2 mM disuccinimidyl glutarate (DSG,
ThermoFisher Scientiﬁc). DSP, DTSSP, and DSG must ﬁrst
be dissolved in DMSO to a concentration of 25 mM before
adding dropwise to the PBS. Gels were then incubated in 375
mM Tris-HCl pH 8.8 buﬀer (when resolving by SDS-PAGE
gradient gel) or 125 mM Tris-HCl pH 6.8 (when resolving by
nongradient SDS-PAGE gel), both containing 2% SDS for 1 h at
room temperature.
2D-SDS-PAGE. Excised gel strips were placed in-between
Mini PROTEAN system glass plates with a 1 mm spacer (Biorad,
Hercules, CA). Each gel strip was positioned with the lowest
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percentage gel facing down (to ensure proteins leave the gel strip
during electrophoresis). When 6%T BN-PAGE gel was used the
orientation of the gel strip was not crucial. Approximately 30 mm
space is needed on the end of the gel strip for comb placement to
form twowells. The glass plates containing the gel strip were then
locked into the Bio-Rad gel stand and checked for leaks. Then a
3−16%T linear gradient or 12%T gel was poured between the
glass plates leaving approximately 10mm space under the excised
gel piece for the sample gel. For 12%T gel, a 1 cm space was left
for the stacking gel to ensure suﬃcient band focusing. Butanol
was gently layered over the top of the gradient, and the gel was
allowed to polymerize at room temperature for ∼1 h. Once the
Figure 1. Electrophoretic mobility α-synuclein during BN-PAGE is determined by sample preparation. (A) Rat brain tissue lysates were resolved under
typical blue native polyacrylamide gel electrophoresis (BN-PAGE) conditions. A total of 25 mg of rat brain tissue was homogenized in 1 mL of blue
native page (BN-PAGE) sample buﬀer (50 mMBisTris, 6 NHCl, 50 mMNaCl, 10% vol/vol glycerol, 0.001%m/vol Ponceau S, pH∼ 7.2). Then either
1% m/vol digitonin (Dig.) or 0.5% vol/vol NP40 was added to the sample and incubated at 4 °C for 30 min. Samples were then centrifuged at 18 000g
for 30 min at 4 °C, and the supernatant (S1) was retained. Protein concentration of the S1 was determined using bicinchoninic acid (BCA) assay
(ThermoFisher). In total, 10 μg and 50 μg of brain tissue lysate protein were resolved using BN-PAGE. Proteins were then immunoblotted onto
polyvinylidene ﬂuoride (PVDF) membranes and blue dye removed by washing the membrane with 100% methanol. PVDF membranes were then
stained with ponseau S, imaged, and subsequently probed with both polyclonal and monoclonal anti-α-synuclein antibodies. (B) Rat brain tissue was
then disrupted under high tissue to buﬀer ratio (m/vol) and separated by BN-PAGE. To do this, 200 mg rat brain tissue was homogenized, as described
above, in 1 mL of BN-PAGE sample buﬀer in the absence of detergents. A total of 5−50 μg of total protein input of the undiluted S1 fraction was loaded
into the ﬁrst six wells of BN-PAGE gel. The S1 sample was then serial diluted from 0.8 to 4 mg protein/mL and 30 μg of protein loaded into the
remaining wells (last six lanes). (C) Rat brain tissue lysates separated by BN-PAGE in two dimensions. A total of 200 mg of rat brain tissue was
homogenized as described above. In total, 30 μg of the lysate was then resolved on a 2.8−13%T BN-PAGE gel. The gel lane was then excised and cast
into a 2.8−13%T BN-PAGE gel perpendicular to the ﬁrst dimension direction of migration. The sample was separated again via 2.8−13%T BN-PAGE.
Top panel represents the immunoblot of ﬁrst dimension BN-PAGE and the middle panel depicts immunoblot following the second dimension BN-
PAGE. Bottom panel depicts ponseau S staining of the blotted proteins from the second dimension BN-PAGE. All membranes were probed with anti-α-
synuclein antibodies and the appropriate HRP conjugated secondary antibodies. All separations shown were conducted using 2.8−13%T linear gradient
BN-PAGE gels. Blue arrows indicate the direction of migration during BN-PAGE electrophoresis. All data representative of 3−10 experiments.
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gel was polymerized, the butanol was removed and a sample gel
of 3%T was poured around the gel strip. Tilting the gel stand
slightly prevented bubbles from forming under the gel strip
bubbles. The two-well comb was placed in between the glass
plates and 30 min was allowed for polymerization. Alternatively,
2D-SDS-PAGE gels can also be precast (without the excised gel
strip). However, this requires custom well comb, which can be
fashioned out of polystyrene sheets purchased from most hobby
stores. Reduction in band resolution, due to uneven migration of
the sample out of excised gel, was observed when using precast
gels and therefore the method should generally be avoided. Gels
were then run at 125 V until the dye front reached the end and
gels were then transferred to PVDF membrane in Towbin
transfer buﬀer (25 mM Tris-HCl, 192 mM glycine, and 20%
methanol) using the constant of 20 V for ∼16 h at 4 °C.
Immunodetection. Dried membranes were reactivated in
100% methanol for 1 min and then rinsed with ultrapure water.
To conﬁrm even transfer, all membranes were stained using
Ponceau S (Sigma-Aldrich). Membranes were incubated in
blocking buﬀer which consisted of 5% m/vol milk diluted in
TBST (50 mM Tris-HCl, 150 mM NaCl, 0.05% Tween-80, pH
8.0) for 1 h at room temperature. Then membranes were
incubated in blocking buﬀer containing either monoclonal (BD
Biosciences) or polyclonal (Santa-Cruz) anti-α-synuclein anti-
bodies diluted 1:1000, overnight at 4 °C. Parkin monoclonal and
polyclonal antibodies were diluted 1:1 000 in blocking buﬀer and
incubated with membranes overnight at 4 °C. Membranes were
then washed 2 × 10 min with TBST before incubating in the
appropriate HRP conjugated antibody diluted 1:5 000 in
blocking buﬀer for 1 h at RT. Membranes were then washed 2
× 10 min with TBST, incubated 5 min in enhanced
chemiluminescence substrate (ThermoFisher Scientiﬁc), and
imaged using GE Imagequant LAS 4000 (GE Health Care, Little
Chalfont, United Kingdom).
In-Sample Cross-Linking. Brain tissue lysates in PBS (see
Sample Preparation) were diluted to concentrations ranging
between 0.1 and 4 mg protein/mL. DSP or DSG (1 mM) were
added to each sample and incubated at 4 °C for 10 min. The
reaction was quenched with 50 mM Tris-HCl pH 8.0 for 15 min.
The 1× SDS-PAGE sample buﬀer (50 mM Tris-HCl pH 6.8, 2%
SDS, 10% glycerol, and 0.1% bromophenol blue) was then added
to each sample, mixed well, and heated at 90 °C for 5 min.
Protein (10 μg) from each sample was added to each well. DSP
cross-linker arm was cleaved by adding 5 mM dithiothreitol
(DTT) prior to heating the sample. Puriﬁed α-synuclein was
dissolved in PBS to a concentration of 4 mg/mL and cross-linked
with 2 mM DSP for 10 min at 4 °C. The reaction was quenched
with 50 mM Tris-HCL pH 8.0 for 15 min.
Determination of Total Lipid Content. Total sample lipid
content was determined essentially as previously described.13
Speciﬁcally, lipids isolated from the samples were dissolved in
100 μL of chloroform. The chloroform solution was then placed
into a disposable 12 mm × 75 mm borosilicate glass tube
(Corning Inc., Corning, NY) and allowed to dry completely.
Standards were generated by dissolving a known mass of isolated
rat brain lipids (see BN-PAGE) or canola oil (local grocery store)
in chloroform. Standard solutions were then pipetted into six
glass tubes to yield 5−400 μg of total lipid and dried completely.
Then, 100 μL of concentrated sulfuric acid (Sigma-Aldrich) was
placed in each tube and incubated at 90 °C for 20 min. The tubes
are then cooled immediately using an ice water bath, and
solutions are transferred to a clear polystyrene 96-well plate
(Thermoﬁsher). Light absorbance was measured at the wave-
length 540 nm, then 50 μL of phosphor-vanillin solution (0.2 mg
of vanillin dissolved in 1 mL of 17% phosphoric acid) was added,
and the plate was incubated at room temperature for 10 min. The
plate was then read at 540 nm again, and the background (i.e.,
ﬁrst absorbance measurement) was subtracted from sulfo-
phospho-vanillin absorbance (i.e., second absorbance measure-
ment). The detection limit was determined to be approximately
5 μg of lipid.
Polyacrylamide Gel-Solutions. All gels were formed using
two stock polyacrylamide solutions. The ﬁrst 40%T acrylamide
stock solution that can be purchased (Biorad) was used for all
SDS-PAGE gels. The second 40%T acrylamide stock solution is
made bymixing 48 g of acrylamide (Fisher Scientiﬁc) and 1.5 g of
N,N-methylenebis(acrylamide) (Fisher Scientiﬁc) in 100 mL of
ultrapure water (heating to 40 °C required to dissolve
completely). This second acrylamide solution was used only
for BN-PAGE gels. BN-PAGE gel buﬀers were prepared as
previously described.14 Stacking gel buﬀer (125 mM Tris-HCl
pH 6.8, 0.1%m/vol SDS) and resolving gel buﬀer (375 mMTris-
HCl pH 8.8, 0.1% m/vol SDS) were used for all SDS-PAGE gels.
The 0.1% m/vol ammonium persulfate (Sigma) and 0.05% vol/
vol N,N,N′,N′-tetramethylethylenediamine (Sigma) were used
to the initiate polymerization of SDS-PAGE polyacrylamide gels.
Blot Quantiﬁcation. Densitometry analysis was conducted
on all images using Imagej software (National Institutes of
Health). Linear regression analysis and t-tests were conducted
using Graphpad Prism software (La Jolla, CA). All images are
uncut (unless depicted by a black line) and representative of each
experiment conducted. Several overexposed images are
presented to display banding pattern, but these images were
not used for any quantiﬁcation.
■ RESULTS/DISCUSSION
Electrophoretic Mobility of α-Synuclein during BN-
PAGE Is Dependent on Sample Preparation. To develop
the multimer-PAGE protocol we ﬁrst needed to describe, in
detail, the migration pattern of α-synuclein during BN-PAGE
(Figure 1). Extraction of proteins from rat brain tissue using 0.5%
NP40, 1% digitonin, or in the absence of detergent under typical
lysis concentrations (25 mg tissue/mL buﬀer) showed eﬃcient
tissue solubilization, an absence of abundant high molecular
weight (>150 kDa) α-synuclein interactions and allowed for the
separation of soluble α-synuclein via BN-PAGE (Figure 1A).
Monoclonal and polyclonal antibodies against the C-terminus of
α-synuclein produced similar band patterns for tissue lysates. α-
Synulcein migrated to the gel position of approximately 50−146
kDa on the 2.8−13%T BN-PAGE gel. The addition of up to 50
μg lysate protein still produced onemajor band at 50 kDa. Amass
shift to approximately ∼100 kDa was observed following the
extraction with digitonin and NP40. The overall protein
distribution on BN-PAGE appeared similar between extraction
conditions, with the exception of an increased abundance of
observable protein complexes with digitonin and NP40 (Figure
1A, Ponseau S stain). Together, these results show that under
typical BN-PAGE conditions soluble α-synuclein from rat brain
tissue was separated as a single species, predominantly migrating
between the 50−146 kDa position on BN-PAGE, in agreement
with several reports.4,15
Previous reports demonstrate high lysis concentrations
preserve α-synuclein multimers.7 Therefore, we then resolved
high concentration rat brain tissue lysates (200 mg tissue/1 mL
buﬀer) in the absence of detergents and observed several α-
synuclein species migrating to 50 kDa, ∼100 kDa, 600 kDa, and
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.6b00419
Anal. Chem. 2016, 88, 4071−4084
4074
Figure 2. Sample lipid content determines the migration of α-synuclein during BN-PAGE. (A) 200 mg rat brain tissue was homogenized in 1 mL of blue
native page (BN-PAGE) sample buﬀer (50 mM BisTris, 6 N HCl, 50 mM NaCl, 10% vol/vol glycerol, 0.001% m/vol Ponceau S, pH ∼ 7.2) and
incubated on ice for 30 min. The sample was centrifuged then at 18 000g for 30 min, S1 retained, and protein content determined using bicinchoninic
acid (BCA) assay. Samples were then adjusted to a ﬁnal concentration of 2 mg protein/mL. A volume of 150 μL of the samples were mixed with 600 μL
of methanol and 150 μL of chloroform. A volume of 450 μL of ultrapure water was then added to the sample and mixed thoroughly. Following
centrifugation at 18 000g for 5 min, the upper aqueous phase was discarded and the lower phase resuspended in 600 μL of methanol. The sample was
centrifuged at 18 000g for 5 min. The liquid was discarded and precipitate (proteins) retained. Separately, bulk lipids were isolated by homogenizing 1 g
of rat brain tissue in amixture of chloroform andmethanol (2:1). Following sonication for 2min, the homogenate was vortexed well, 4 mL of PBS added,
and vortexed again. The sample was then allowed to sit for 5 min to allow the solution to separate into two phases. The organic phase containing the
puriﬁed lipids was removed and dried under vacuum. The lipid pellet was then completely dissolved in 200 μL of 10% NP40. The precipitated lipid free
proteins were dissolved in BN-PAGE sample buﬀer, BN-PAGE sample buﬀer containing 0.5% w/v NP40, or BN-PAGE sample buﬀer containing 0.5%
w/v NP40 mixed lipid micelles. Samples were mixed thoroughly, incubated on ice for 30 min, and mixed thoroughly again. All samples were then
centrifuged at 18 000g and the resulting 10 μg of protein of the soluble fraction resolved by BN-PAGE. Top panel depicts immunobloting of samples
with anti-α-synuclein antibody.Middle panel depicts the white light image of polyvinylidene ﬂuoride (PVDF)membrane immediately following transfer
of the BN-PAGE gel. Bottom panel depicts ponseau S staining of PVDF membrane following the removal of G250 from the membrane by washing in
100%methanol for∼5min. (B) 25, 50, 100, and 200mg of rat brain tissue was homogenized in 1 mL of BN-PAGE sample buﬀer as described above and
resolved via BN-PAGE. A total of 30 μg of total proteins were resolved in each lane without sample dilution (left column panels) and following dilution
of samples to 2 mg protein/mL (right column panels). Top row depicts white light image of PVDF membrane immediately following transfer. Middle
row depicts subsequent ponseau S staining of the PVDF membrane following removal of G-250. Bottom row depicts the immunoreactivity of α-
synuclein. (C) Increasing concentrations of G-250 (0−2%) was added to rat brain tissue lyates from high concentration homogenization conditions
(200 μg tissue/mL buﬀer). A total of 30 μg of protein was then resolved via BN-PAGE. Top panel depicts white light image of PVDFmembrane. Middle
row depicts ponseau S staining of PVDFmembrane following removal of G-250. Bottom row dipicts the immunoreactivity of alpha-synuclein. (D) Lipid
to protein content of insoluble fraction following tissue homogenization at diﬀerent tissue to buﬀer ratios.
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1048 kDa following BN-PAGE (Figure 1B). The mass shift of α-
synuclein was sensitive to both total protein input, and to some
extent, sample dilution. Under conditions of high sample
concentration and/or high total protein input α-synuclein
preferentially migrates to the 100 kDa BN-PAGE gel position.
At the highest total protein input (50 μg protein) the
predominant species of α-synuclein had an apparent mass of
100 kDa and two other massive species, at 600 kDa and 1048
kDa, could clearly be observed, albeit far less abundant than the
100 kDa position. The mass shift of α-synuclein during BN-
PAGE was not completely lost following dilution of the sample,
suggesting that the sample concentration at initial tissue lysis was
also a crucial factor for the observed BN-PAGE mass shift.
Interestingly, once the majority of α-synuclein had shifted to 100
kDa, several minor bands remained at the original position (more
clearly seen in Figure 2B, bottom panel) suggesting the original
band may be comprised of several species with distinct masses.
Together, these results show that α-synuclein migrates to several
positions on BN-PAGE depending on how the sample is
prepared and that an unknown dilution sensitive factor was
responsible for this apparent mass shift.
Next, we tested whether the observed α-synuclein mass-shift
was a progressive process (i.e., a product of electrophoresis) by
separating tissue lysates via BN-PAGE in two dimensions.
Following the ﬁrst dimension separation of 30 μg of brain lysate
by BN-PAGE one main band at 50 kDa and a minor band just
above ∼100 kDa, were observed (Figure 1C, top panel), as was
shown previously in Figure 1B. When we subsequently separated
the BN-PAGE gel lane by BN-PAGE perpendicular to the
original migration direction, we again observed two distinct α-
synuclein species at 50 kDa and ∼100 kDa (1C, middle panel),
both at the original positions of the 1D-BN-PAGE. This suggests
that the mass shift of α-synuclein during BN-PAGE was either
due to a saturable process (i.e., nonprogressive) or the observed
massive species existed in the original sample. The lack of a
progressive mass shift during the second dimension BN-PAGE
makes it highly unlikely that buﬀer components (i.e., coomassie
blue g-250, Bis-Tris, aminocaporic acid, and tricine) were
responsible for the observed mass shift.
Endogenous Lipids Determine α-Synuclein Migration
Distance during BN-PAGE. An unknown biological factor or
factors, lost upon dilution of the lysate and inﬂuenced the initial
lysis concentration, were causing a mass shift of α-synuclein
during BN-PAGE. Endogenous phospholipids are nearly
insoluble amphiphiles that have the potential to form small
soluble aggregates, termed micelles. Micelles form at threshold
concentrations and are sensitive to dilution.16 Since α-synuclein
is known tomultimerize upon phospholipid membrane binding,5
endogenous lipid micelle-α-synuclein complex could be
responsible for the α-synuclein mass shift during BN-PAGE.
To test whether endogenous lipids were responsible for the
apparent mass shift of α-synuclein, we removed lipids from the
brain tissue lysates and then resolved the lipid free proteins by
BN-PAGE. We found α-synuclein formed one distinct 50 kDa
species in the absence of endogenous lipids (Figure 2A) similar
to what was observed in low-lysis concentration detergent free
samples (See Figure 1A). When 0.5% NP40 was added to lipid
free proteins we observed a mass shift too approximately of∼100
kDa with only a small amount of the 50 kDa α-synuclein species
remaining (visualized a small spots toward the perimeter of the
lane). Themass shift was similar to that observed with BN-PAGE
of NP40 tissue extracts (Figure 1A). NP40/brain-lipid mixed
micelles were then added to the lipid free proteins and another
mass shift was observed, with α-synuclein now running at ∼50,
∼100, and ∼200 kDa, similar to that observed in the detergent
free high concentration samples (refer to Figure 1B). Therefore,
lipid and detergent micelles alone could produce a substantial
apparent mass shift (+400% mass) during 1D-BNP. Interest-
ingly, the micelles and endogenous lipids could be observed on
the back of PVDF blots of the BN-PAGE following transfer,
mostly stacked at the bottom of the membrane (Figure 2A,
middle panel). Strikingly, the α-synuclein migration pattern was
identical to the observed micelle migration pattern on the PVDF
membrane. Ponceau S staining conﬁrmed that the observed
micelle positions were not highly proteinaceous (i.e., below
ponseau S detection threshold, ∼10 μg of protein per lane).
Taken together this data demonstrates that α-synuclein was
migrating with endogenous lipids and/or detergent micelles
during BN-PAGE, and this eﬀect was likely responsible for mass
shifts observed when tissue was disrupted at high concentrations.
When we resolved brain lipid/detergent mixed micelles by
BN-PAGE, we noticed that they could be clearly visualized
following transfer to PVDF membranes (Figure 2A, middle
panel). Next we asked whether a similar pattern could be
observed when tissue was lysed at high concentrations. Such a
pattern would presumably conﬁrm the hypothesis of endogenous
lipid micelles being responsible for the observed mass shift
during BN-PAGE. Results show that indeed the same type of
pattern was observable most noticeably when tissue was lysed at
high concentrations (Figure 2B, top panel). As with the lipid/
detergent micelles, α-synuclein migration patternedmirrored the
apparent endogenous lipid structures (Figure 2B, bottom panel)
following BN-PAGE. Dilution of the samples did not abolish the
visualization of the lipids but instead resulted in their shift to
lower, discrete bands. Again, α-synuclein migration mirrored the
position shift of the endogenous lipid micelles upon sample
dilution. Gross protein distribution was relatively unaﬀected by
the lipid structures migrating on BN-PAGE (Figure 2B, middle
panel). Together, these observations demonstrate that α-
synuclein was comigrating with soluble endogenous lipid
structures.
Coomassie G-250 incorporates into detergent micelles,17
imparting a net negative charge, carrying them to the dye front
during BN-PAGE, ultimately preventing distortion of protein
separation.18Wewanted to determine whether G-250 could alter
the distribution of the apparent endogenous lipid micelles and
produce a corresponding mass shift in α-synuclein. When 0.01−
1% G250 was added directly to samples from high concentration
lysis conditions, the original lipid smear on the PVDFmembrane
was no longer observable (Figure 2C, top panel). Gross protein
migration appeared unaﬀected by G-250 treatments (Figure 2C,
middle panel), but α-synuclein migration became more focused
to a position of 50 kDa as the G-250 concentration increased
(Figure 2C, bottom panel). Therefore, excess G-250 added
directly to the sample prevents the lipid mediated mass shift
during BN-PAGE.
Lipids extracted under high concentration lysis conditions
determined the electrophoretic mobility of α-synuclein during
BN-PAGE; however, it was unclear whether high concentration
tissue lysis resulted in increased lipid extraction from tissue. To
directly address this, we measured the lipid and protein content
in the remaining insoluble pellet (P1) at several lysis
concentrations (Figure 2D). Results showed a sharp decrease
in the lipid/protein ratio in the insoluble pellet when tissue was
disrupted at high concentrations (i.e., 50−200 mg tissue/mL
buﬀer). Interestingly, all lysis conditions above 50 mg tissue/mL
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buﬀer had similar lipid extraction eﬃcacy. We attempted to
directly measure the lipid content in S1 fractions, but the lipid
concentration was near the assay’s threshold for detection (∼5
μg of lipid) and we were unable to obtain quantitative results.
Even without the S1 lipid concentration it was clear that high lysis
concentrations were increasing ratio of lipid to protein extracted
from tissue.
Mass shift of a protein during BN-PAGE electrophoresis is
commonly interpreted as a formation of protein complexes.
However, as we have demonstrated here, the electrophoretic
mobility of α-synuclein during BN-PAGE can vary drastically
depending on sample preparation (speciﬁcally sample lipid
content). A previous report demonstrated a similar eﬀect for the
mitochondrial ADP/ATP carrier protein AAC3.19 Therefore,
BN-PAGE alone is insuﬃcient to accurately detect and describe
soluble α-synuclein multimers.
α-Synuclein Multimers Can Be Resolved via SDS-PAGE
Following In-Gel Chemical Cross-Linking. Chemical cross-
linking methods can be used to selectively capture protein−
protein interactions. Once protein−protein interactions are
Figure 3. In-gel chemical cross-linking reveals several soluble α-synuclein multimers following BN-PAGE. Rat brain tissue was homogenized in blue
native page (BN-PAGE) sample buﬀer (50 mM Bis-Tris, 6N HCl, 50 mMNaCl, 10% vol/vol glycerol, 0.001% m/vol Ponceau S, pH∼7.2) at a ratio of
200 mg of wet tissue to 1 mL of buﬀer. Following centrifugation at 18 000g for 30 min at 4 °C, the protein content of the S1 fraction was determined by
bicinchoninic acid (BCA) assay. (A) 30 μg protein per lane was resolved via BN-PAGE. Individual lanes were then excised, washed with phosphate
buﬀered saline pH 7.4 (PBS), and incubated in PBS solutions containing 0.1 mM dithiobis(succinimidyl propionate) (DSP), 0.1 mM disuccinimidyl
glutarate (DSG), 1% glutaraldehyde (GLUT), or 1% paraformaldehyde (PFA) for 30min at 4 °C. The excised gel pieces were then cast into SDS-PAGE
and run perpendicular to the original migration direction. (B) Rat brain tissue was homogenized in PBS at a ratio of 200 mg wet tissue/1 mL buﬀer.
Samples were centrifuged at 18 000g for 30 min at 4 °C. The sample was then diluted from 4 to 1 mg protein/mL. Following dilution, 1 mM DSG or 1
mMDSPwas added to the samples and incubated for 10min at 4 °C. The reaction was then quenched with 100mMTris- HCl pH 8.0 for 15min at 4 °C.
The 5× SDS-PAGE sample buﬀer was added to each sample, mixed well, and 10 μg of protein loaded into each lane of a 3−16%T SDS-PAGE gel. The 5
mMDTTwas added to the 4 mg protein/mLDSP cross-linked sample to cleave the cross-linker (lane 1). (C) Increasing concentrations of total soluble
protein were resolved via BN-PAGE (from the left; 4, 8, 12, 16, 20, 24, 28, 32, 36, and 40 μg of protein). BN-PAGE gel was cut above and below the 66
kDa molecular weight marker (red dotted box), washed with PBS, incubated with 0.1 mMDSP, and cast into a SDS-PAGE gel. Left panel depicts white
light image of gel following BN-PAGE. Right panel depicts immunoblotting of the second dimension SDS-PAGE. All blots probed with rabbit polyclonal
anti-α-synuclein antibody and appropriate horse radish peroxidase (HRP) conjugated secondary antibody. Images are representative of 3−5 separate
experiments.
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.6b00419
Anal. Chem. 2016, 88, 4071−4084
4077
captured the samples can be separated in the presence of SDS
micelles via traditional SDS-PAGE. SDS solubilizes lipids20 and
denatures proteins,21 thereby avoiding complications involved
with BN-PAGE when separating lipid binding proteins, in this
case α-synuclein. Therefore, following separation of tissue lysates
via BN-PAGE, we incubated BN-PAGE gel lanes in several cross-
linking solutions and then resolved them using 2D-SDS-PAGE
(Figure 3A). Results showed that cross-linking with 0.1 mM
DSP, 0.1 mM DTSSP (not shown), 1% glutaraldehyde, 0.1 mM
DSG, but not 1% PFA produced several highmolecular weight α-
synuclein products in addition to the monomer detected
following 2D-SDS-PAGE. We also observed two massive α-
synuclein species of low abundance that were only captured and
detectable with DSG or DSP. These elute from the BN-PAGE
Figure 4.Optimization of in-gel chemical cross-linking and multimer-PAGE gel format. 10, 20, and 40 μg of rat soluble brain tissue lysate were resolved
by blue native polyacrylamide electrophoresis (BN-PAGE). 2.8−13% linear BN-PAGE gels were cut just above and below the 66 kDa molecular weight
marker following electrophoresis. The excised gel pieces were washed in phosphate buﬀered saline pH 7.4 (PBS) for 30 min at 4 °C. Excised BN-PAGE
gel pieces were incubated with cross-linking solution and cast directly to SDS-PAGE gels. The cross-linked proteins were resolved by SDS-PAGE
perpendicular to the original direction of sample migration. SDS-PAGE gels were then immunoblotted. Excised gel pieces incubated with either (A)
0.1−2mM dithiobis(succinimidyl propionate) (DSP) (B) or 0.1−2mM disuccinimidyl glutarate (DSG). (C) Excised gel pieces incubated with 0.1 mM
DSP for 5−45min. (D) 30 μg of rat brain tissue lysate separated by BN-PAGE, blotted, and probed for parkin (Left panel). 10, 20, 30, and 40 μg of lysate
protein resolved by BN-PAGE. BN-PAGE gel was excised between 40 and 242 kDa positions, incubated with 0.1 mM DSP for 30 min at 4 °C, and
resolved via SDS-PAGE. Immunoblotting for parkin and α-synuclein shown (Right panels). (E) Puriﬁed α-synuclein was dissolved in PBS and diluted to
a concentration of 5 mg protein/mL. The 2 mM DSP was added to the sample and incubated for 10 min at 4 °C. The reaction was quenched with 100
mM Tris-HCl pH 8.0. 200 ng of α-synuclein resolved on 12%T SDS-PAGE. (F) Increasing protein input resolved by 2.8−13%T BN-PAGE and 6%T
BN-PAGE. Samples were allowed to migrate the length of the 2.8−13%T BN-PAGE and the 66 kDa gel position excised as before. In contrast, samples
were allowed to migrate on approximately 2 cm into the resolving gel on the 6%T BN-PAGE, and this 2 cm gel piece excised. In-gel cross-linking was
performed and both excised gel pieces resolved via SDS-PAGE. Bands are labeled with their apparent corresponding species according the standard (E).
Dotted red lines indicate position of gel excision. All blots probed with rabbit polyclonal anti-α-synuclein antibody and appropriate horse radish
peroxidase (HRP) conjugated secondary antibody. Images are representative of three separate experiments.
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positions corresponding to the two high molecular weight
species (∼600 kDa and ∼1048 kDa) clearly seen following BN-
PAGE in Figure 1B. Both species were far less massive on the
SDS-PAGE (∼80 kDa, and 170 kDa, respectively). Because DSP
and DSG cross-linking is relatively speciﬁc for protein−protein
interactions, the 600 kDa and 1048 kDa apparent masses on BN-
PAGEwere like due to processes other than true multimerization
(e.g., lipid/detergent binding), as opposed to true multimers of
600 and 1048 kDa. PFA was ineﬀective at capturing α-synuclein
multimers most likely because the spacer-arm length of PFA is
relatively short (2 Å) while the eﬀective cross-linkers had much
longer spacer arm length (≥7 Å).7 Several other reports have also
demonstrated the successful capture of α-synuclein multimers
using cross-linkers with similar spacer-arm length.4−6
It remained unclear whether any α-synuclein multimers
existed in solution prior to electrophoresis or were products of
BN-PAGE. To address this, we directly cross-linked the soluble
brain extracts using 1mMDSP or DSG and resolved them via 4−
16% SDS-PAGE (Figure 3B). Results show that α-synuclein
multimers could be detected in lystates using both DSP and DSG
cross-linkers. These multimers ranged from 34 kDa to >170 kDa
and appeared to be formed predominantly by diﬀusion mediated
cross-linking. Serial dilution of the sample prior to cross-linking
prevented the capture of multimeric species, and for unclear
reasons, also resulted in reduced immunodetection of the
monomer (i.e., 17 kDa). Because directly cross-linking the
sample did not produce α-synuclein multimers comparable to
the in-gel crossslinking of BN-PAGE, the α-synuclein multimers
observed following BN-PAGE were most likely, to some extent,
products of electrophoresis.
Once we had determined that several multimers were found at
the 50−100 kDa positions of the BN-PAGE gel, we then “scaled
up” and optimized the procedure to make comparisons of many
samples more reliable and less time-consuming. To do this we
exploited the observation that under most sample conditions
nearly all native α-synuclein migrated to the ∼50−100 kDa
position on the BN-PAGE gel, and simply cut the gel just below
the 66 kDa marker and just at the 146 kDa marker and ran the
2D-SDS-PAGE parallel to the BN-PAGE lanes (Figure 3C). The
excised gel should encompass the 40−146 kDa positions, to
ensure all α-synuclein is resolved by 2D-SDS-PAGE. This
technique allowed the experimental conditions to be nearly
identical between samples. Using this “scaled up” procedure
would allow the cross-linked α-synuclein products to form more
discrete bands when separated by 2D-SDS-PAGE, as opposed to
smeared blebs observed with running the entire excised lanes,
making them easier to visualize and compare. Several
experimental conditions could now be run on a single gel
making comparisons between the extracts simple and reprodu-
cible. Furthermore, several multimers at the gel position could be
quantiﬁed simultaneously, as opposed to only the typically two α-
synuclein species observed following BN-PAGE. For simplicity,
we termed the entire process as “multimer-PAGE,” with the
presented blots representing the blotted 2D-SDS-PAGE of cross-
linked native complexes.
Optimization of In-Gel Chemical Cross-Linking. Dif-
fusion based chemical cross-linking can randomly covalently
bind proteins forming progressively massive products only
limited by the diﬀusion of the protein in solution. Protocols using
chemical cross-linking of proteins should be carefully validated to
avoid diﬀusion based products, unless the product is desired, as
was later exploited here to produce the α-synuclein multimer
molecular weight “standard” (see Figure 4E). Generally, cross-
linker concentration, time of cross-linking, and the molecular
structure of the cross-linker are manipulated to determine true
products (i.e., those that existed prior to cross-linking) vs
diﬀusion based (i.e., those that formed during cross-linking).
Here we tested two cross-linking molecules DSP and DSG, both
of which have been used in tissue and solution to stabilize α-
synuclein multimers.6 Cross-linking the excised BN-PAGE gel
with as little as 0.1 mM DSP (Figure 4A) or DSG (Figure 4B)
was suﬃcient to capture α-synuclein multimers. For reasons that
are unclear, increasing DSG concentrations appeared to reduce
the detection of both multimeric and monomeric α-synuclein.
Because of the unusual behavior of DSG during in-gel cross-
linking, we chose to use 0.1 mM DSP for the remaining studies.
The main α-synuclein species observed following in-gel cross-
linking was smeared between 34 and 130 kDa on the SDS-PAGE.
Next we tested what cross-linker incubation time was optimal to
capture the multimers (Figure 4C). Gels incubated with 0.1 mM
DSP for 5 min preferentially capture αS80. The cross-linking
time to capture multimers was so rapid it strongly suggested that
diﬀusion based cross-linking was not a main driving factor of α-
synuclein multimers detection following multimer-PAGE
protocol. Cross-linking produced nearly equal multimer
abundance at 30 and 45 min, and therefore 30 min was chosen
for the remaining studies.
During validation of the multimer-PAGE protocol, we
observed that optimal resolution of cross-linked products during
SDS-PAGE requires that excised gel pieces be cast directly into
the SDS-PAGE gel as described in the methods. Alternatively,
when gel pieces were placed directly on top of a preformed SDS-
PAGE gel (also mentioned in methods) lane distortion became
evident (see Figure 4C) but did not appear to eﬀect
quantiﬁcation. Therefore, this method can be used when sample
processing speed is crucial, as it is more time intensive to cast
excised gels directly into SDS-PAGE gels. We also observed that
using a 12%T SDS-PAGE with a stacking layer ultimately
provided superior band resolution to 3−16%T SDS-PAGE gels.
Next we tested the speciﬁcity of multimer-PAGE for α-
synuclein. To do this we ran the multimer-PAGE protocol and
probed for the E3 ligase parkin, a small globular soluble protein
not known to interact with lipids or form progressively massive
multimers. We found that parkin also migrates to approximately
the same BN-PAGE gel position as α-synuclein (Figure 4D),
making it a good internal control. Following multimer-PAGE we
observed no detectable cross-linked parkin multimers following
multimer-PAGE protocol. Instead we saw one species located at
∼43 kDa. This position is slightly below the 50 kDa position
where parkin is normally found. The slight discrepancy in
molecular weight of parkin is likely due to the stabilization of a
compact tertiary structure of parkin by chemical cross-linking,
which can increase proteins mobility on SDS-PAGE.22,23 The
migration of parkin during multimer-PAGE was in stark contrast
to α-synuclein, which under the same experimental conditions
produced abundant multimers. This ﬁnding demonstrates that
multimer-PAGE is relatively speciﬁc for α-synuclein and gross
diﬀusion based protein cross-linking was not a key factor.
To determine stoichiometry of α-synuclein multimers
following multimer-PAGE we generated a molecular weight
“standard” by cross-linking concentrated puriﬁed α-synuclein (5
mg puriﬁed α-synuclein/1 mL) with 2 mM DSP and separated
the resulting products by SDS-PAGE (Figure 4E). Results show
ﬁve species at gel positions corresponding to the molecular
weights of 17 (αS17), 35 (αS35), 56 (αS56), 80 (αS80), and 100
kDa (αS100). α-Synuclein was detected above 130 kDa position
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.6b00419
Anal. Chem. 2016, 88, 4071−4084
4079
but was poorly resolved by SDS-PAGE and therefore was
disregarded as a deﬁned α-synuclein multimers species. The
observed multimers were likely captured primarily via diﬀusion
controlled cross-linking because there was an inverse relationship
between multimers abundance and the observed molecular
weight, which likely occurs if multimers were cross-linked in a
stepwise fashion.
We next wanted to determine the optimal polyacrylamide gel
format for multimer-PAGE (Figure 4F).We found that 6%TBN-
PAGE gel followed by 12%T SDS-PAGE gel provided the
greatest resolution of α-synuclein multimers with the least eﬀort.
We simply ran the 6%T BN-PAGE gel (with 2.8%T well gel) at
100 V until all soluble proteins had migrated ∼2 cm into the
resolving gel. The gel was excised as before and cast into the 12%
T SDS-PAGE. The new gel format had several key advantages:
(1) avoided hand pouring linear gradient polyacrylamide gels
which can be time-consuming and have poor reproducibility, (2)
ensured all α-synuclein (and other proteins) in the sample was
resolved by multimer-PAGE, (3) cross-linked products migrated
out of a single 6%T BN-PAGE gel to the SDS-PAGE gel more
consistently allowing for increased band resolution, (4) allowed
for investigation of protein complexes other that α-synuclein
without extensive validation of BN-PAGE migration (i.e., do not
need to know a BN-PAGEmigration pattern), and (5) faster BN-
PAGE run times (∼30 min at 100 V).
Optimization of Brain Tissue Sample Preparation and
Separation. Once in-gel cross-linking and electrophoresis
conditions were optimized, we then tested the inﬂuence of
sample preparation on multimer-PAGE output. First, we
investigated whether lipid content of the sample would alter
the observed multimer pattern. We had already observed that α-
synuclein migrated with endogenous brain lipids during BN-
Figure 5. Sample preparation determines observed multimer abudance and pattern. Rat brain tissue was homogenized in blue native page (BN-PAGE)
sample buﬀer (50 mM BisTris, 6 N HCL, 50 mMNaCl, 10% vol/vol glycerol, 0.001% m/vol Ponseau S, pH∼7.2) at a ratio of 200 mg wet tissue/1 mL
buﬀer. Following centrifugation at 18 000g for 30 min at 4 °C, the protein content of the S1 fraction was determined by the bicinchoninic acid (BCA)
assay. (A) 300 μg proteins from the sample was precipitated and resusupended in either BN-PAGE sample buﬀer containing either 0.5% NP40 or 0.5%
NP40mixed lipid micelles. Protein (10 μg) was resolved bymultimer-PAGE. (B) 50−200 ng of puriﬁed α-synuclein and 30 μg of brain tissue lysate were
resolved via multimer-PAGE. (C) 0−1% G250 directly added to S1 samples. 30 μg of these samples was separated by multimer-PAGE. (D) Rat brain
tissue was disrupted in BN-PAGE sample buﬀer at a tissue mass to buﬀer ratio of 25, 50, 100, and 200. A total of 30 μg of protein from each lysis
condition was resolved via multimer-PAGE. SDS-PAGE of S1 and P1 found in the bottom two panels. (E) Rat brain tissue was homogenized in a tissue
mass to a buﬀer ratio of 25 and 100. Increasing total protein input was then resolved via multimer-PAGE. (From the left: 5, 10, 20, 30, and 40 μg protein).
All samples were centrifuged at 18 000g for 30min prior to BN-PAGE. All blots probed with rabbit polyclonal anti-α-synuclein antibody and appropriate
horse radish peroxidase (HRP) conjugated secondary antibody. Images are representative of 2−4 separate experiments.
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PAGE (Figure 2A−C); however, when we assessed these
samples using multimer-PAGE we found little evidence of any
multimeric α-synuclein species in any of the samples (Figure
5A). Neither proteins alone nor proteins reconstituted into lipid/
detergent micelles produced detectable multimers. This suggests
that although α-synuclein was strongly interacting with lipid/
detergent mixed micelles the binding to these micelles alone was
insuﬃcient to produce multimers. Furthermore, multimers
observed following multimer-PAGE of tissue lysates were likely
not due to protein−lipid cross-linking, as these products would
then be predicted to be in abundance in the presence of excess
brain lipids. However, phosphatidalserine and phosphatidyle-
thanolamine both contain primary amines so protein−lipid
cross-linked products cannot be conclusively ruled out.
Since recombining separated components (i.e., lipids and
proteins) of complex biological samples did not produce
detectable multimers by BN-PAGE, we wanted to determine
whether α-synuclein alone could assemble into multimers during
multimer-PAGE. To test this we resolved increasing α-synuclein
input (50−200 ng) by multimer-PAGE and found multimers, to
a limited extent, could be detected (Figure 5B). However,
multimers from puriﬁed α-synuclein required excess protein
input and were qualitatively distinct from those found in tissue
lysates. High molecular weight α-synuclein multimers (i.e., αS56,
αS80, and αS100) are preferentially detected in lysates while
αS35 is the primary multimer detected when using puriﬁed α-
synuclein. The multimer pattern when using puriﬁed α-synuclein
was indicative of diﬀusion based cross-linking and distinct from
multimers from lysates, as previously reported.7 Therefore, α-
synuclein was insuﬃcient to produce multimers observed in
complex biological samples.
G-250 incorporates into micelles and can form micelle like
structures in water, and therefore we wanted to know whether G-
250 could aﬀect multimer detection (Figure 5C). G250 added
directly to the sample produced an increased multimer
abundance only when G-250 concentrations were relatively
high (0.5% and 1%). G-250 concentrations below 0.5% (ﬁrst
three lanes) were similar in multimer abundance and
distribution. Because samples are not typically exposed to G-
Figure 6.Multimer-PAGE can be used to compare many complex biological samples. Brain tissue from 4 male Sprague−Dawley rats was weighed and
homogenized in BN-PAGE sample buﬀer (100 mg tissue/mL buﬀer). Samples were centrifuged at 18 000g for 30 min at 4 °C. The supernatant was
retained and 10, 20, and 30 μg of protein separated by multimer-PAGE. Multimer-PAGE of samples from the hypothalamus (A) and cortex (B). Top
panels depict immunoblotting for α-synuclein. Bottom panels depict ponseau S stain of multimer-PAGE blots prior to immunoprobe. (C) The ratio of
17 kDa (αS17) to 80 kDa (αS80) α-synuclein was calculated using ImageJ software and values are plotted for each protein input. The R2 for each line is
depicted on the graph. (D) Bar graph comparing the multimer curve slopes between the two brain regions. (“Rate of multimer formation” = slope of
multimer curves. *students t test, t (6) = 11.29, p < 0.0001, n = 4).
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.6b00419
Anal. Chem. 2016, 88, 4071−4084
4081
250 concentrations above 0.5% duringmultimer-PAGE protocol,
this eﬀect is likely minimal.
Previously we demonstrated that disruption of brain tissue at
high concentrations increased relative lipid extraction and altered
the migration of α-synuclein during BN-PAGE (see Figure 2D,
Figure 7. Final optimized protocol for α-synuclein multimer-PAGE. First, rat brain tissue was homogenized in blue native page electrophoresis (BN-
PAGE) sample buﬀer (50 mM BisTris, 6 N HCl, 50 mM NaCl, 10% vol/vol glycerol, 0.001% m/vol Ponseau S, pH ∼7.2 ) at a speciﬁc buﬀer to tissue
ratio (100 mg of wet tissue per 1 mL of buﬀer) (top panel). Homogenization was conducted on ice and consisted of 30 gentle strokes in a 7 mL glass
dounce homogenizer. Samples were then centrifuged for 30 min at 18 000g, and the supernatant (S1) containing the soluble biological molecules was
retained. Samples were then prepared to load into a BN-PAGE gel (see Step II). To do this, protein content of this sample was then determined using
bicinchoninic acid (BCA) assay and the S1 diluted to 2mg protein/mL using BN-PAGE sample buﬀer. In order to compare samples, 10, 20, and 30 μg of
each sample was loaded into a 6%T BN-PAGE gel. A 100 V potential was applied to the gel until the sample had migrated to approximately 2 cm into the
resolving layer of the 6%T BN-PAGE gel. The gel was then removed, well gel discarded, and the 2 cm section of gel containing the samples was excised.
The excised gel piece was then washed in phosphate buﬀered saline pH 7.4 (PBS) for approximately 30 min at 4 °C (see step III). The PBS solution
should be changed at least 3 times during the washing. Then the gel piece is placed in 10 mL of PBS and 40 μL of 25 mM dithiobis(succinimidyl
propionate) (DSP) dissolved in DMSO added to the PBS. The gel is incubated in this cross-linking solution for 30 min at 4 °C, then the solution is
discarded and replaced with quenching solution (125 mM Tris-HCL pH 6.8, 2% SDS) and incubated for 60 min at room temperature. The excised gel
piece is then placed between glass plates and cast into 12%T SDS-PAGE gel. A constant voltage of 100 V is then applied to the gel using SDS-PAGE
running buﬀer until coomassie dye has left the end of the gel. The 12%T SDS-PAGE gel was then electroblotted onto polyvinylidene ﬂuoride (PVDF)
membranes and probed with several α-synuclein antibodies (see Step IV). Densitometry analysis can then be conducted on the observed bands using
imageJ software. The slope of the lines plotting multimer abundance and total protein input could be used to compare samples. (“ST” = well for
molecular weight standard)
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.6b00419
Anal. Chem. 2016, 88, 4071−4084
4082
B), so we explored whether the ratio of tissue to lysis buﬀer
inﬂuenced the abundance of observed multimers. Results
showed that when tissue was disrupted at increasing concen-
trations, multimers in the S1 fraction were in greater abundance
but the pattern was relatively unchanged (Figure 5D). αS80 and
αS100 appeared to be particularly abundant with αS56 being
lower in abundance. Interestingly, the total amount of α-
synuclein extracted (i.e., S1 fraction) per protein was similar
when 50 mg tissue per mL buﬀer or greater was used for tissue
lysis. Despite the similar extraction eﬃcacy, multimers were
clearly more abundant with increasing ratio of tissue to buﬀer.
Both the 100 and 200 mg tissue per mL buﬀer showed nearly the
same multimer abundance, and therefore the 100 mg tissue per
mL buﬀer condition was selected for multimer quantiﬁcation.
Few multimers were detected at typical tissue lysis
concentration (i.e., 25 mg tissue/mL buﬀer) when 20 μg of
total protein was input into multimer-PAGE (see Figure 5D).
However, our previous data suggested that, to some extent, α-
synuclein multimers were being formed during electrophoresis
(see Figure 3C,B). Therefore, we next asked whether increasing
sample input from low and high lysis concentrations would
produce observable multimers. Results show that as sample input
increased, multimers became more abundant in both the low and
high concentration tissue lysis samples (Figure 5E). α-Synuclein
multimers were detectable with 10 μg of protein in the high
concentration lysis but required 15 μg following low
concentration tissue lysis. Multimer-abundance increased
disproportionally to monomer abundance following both lysis
concentrations. This observation, as seen previously (Figure 3C),
seems to support the idea that multimers were forming during
multimer-PAGE and do not exist in the original sample.
Therefore, although lysis at high concentration allows for ease
of multimer detection, it does not seem absolutely necessary to
produce multimers given sample input into the multimer-PAGE
is suﬃciently high.
UsingMultimer-PAGE toMeasure the Stoichiometry of
α-Synuclein Multimers in Biological Samples. Next we
wanted to determine a standardized method to analyze the data
produced by multimer-PAGE. To do this we exploited the
observation that the ratio of αS80 to αS17 increases linearly with
increasing protein input into multimer-PAGE (see Figure 6C).
This phenomenon allowed the assessment of multimerization
while avoiding variability from factors such as relative α-synuclein
abundance in the sample.
We generated a multimer curve by separating 10, 20, and 30 μg
protein of lysates from the rat hypothalamus (Figure 6A) and
frontal cortex (Figure 6B) via multimer-PAGE. Care was taken to
ensure tissue was disrupted in 1 mL of BN-PAGE sample buﬀer
per 100 mg of tissue. Once the multimer curve was generated
(Figure 6C) we could plot the ratio of αS80 to αS17 at each
protein input. The corresponding slope of the multimer curve
could then be calculated and compared. We refer to the
calculated slope as the rate of multimer formation because the
line likely represents the propensity of α-synuclein to form
multimers during multimer-PAGE. We then compared multimer
formation between two distict brain regions (Figure 6D). Results
show, that within each brain region, animals had similar rate of
multimer formation, resulting in very little variability. However,
when we compared the two brain regions there was signiﬁcant
(Students t test, t (6) = 11.29, p < 0.0001, n = 4) reduction in the
rate of multimer formation in the hypothalamus when compared
to the frontal cortex. The signiﬁcance the regional diﬀerence in
multimer formation is not realized here, but the method appears
to provide reproducible and accurate measurement of the α-
synuclein multimer abundance between diﬀerent biological
samples.
Final Optimized Protocol for α-Synuclein Multimer-
PAGE. The ﬁnal optimized protocol for α-synuclein multimer-
PAGE involves four key steps and takes approximately 1 day to
complete (Figure 7). With this protocol we could routinely
measure and compare several high molecular weight α-synuclein
species across complex biological samples. Eﬀort was taken to
ensure the process was not overly complicated and could be
conducted using common lab equipment. Although this protocol
was optimized for α-synuclein detection, it should be emphasized
that experimentation with protein separation, cross-linking, and
sample handing conditions could potentially help answer
questions about numerous other protein complexes. This
technique likely has broad applicability to the study of the
stoichiometry of numerous other protein-complexes. Although
the current protocol is limited to measuring “low-n” multimers
consisting of ∼10 or less α-synuclein molecules, the SDS-PAGE
gel format could be easily adjusted to study ever more massive
multimeric species.
■ CONCLUSIONS
α-Synuclein formed several soluble multimers during BN-PAGE
provided that lipid interactions were preserved during tissue lysis.
Preservation of lipid interactions likely stabilized α-synuclein
secondary structure8,24 subsequently “seeding” multimer for-
mation3 and/or stabilizing existing multimers. We found that a
practical method to preserve lipid interactions involved
disrupting the tissue in small buﬀer volumes (i.e., 50−200 mg
tissue/mL buﬀer) in the absence of detergents. The high ratio of
tissue to buﬀer increased the extraction of lipids from tissue.
Extracted lipids behaved like endogenous micelles. Although we
did not provide a direct description of these micelles, they are
logically consistent with the fact that free phospholipids are
almost completely insoluble in water and the lipid structures
migrated on BN-PAGE as complexes (i.e., above the dye front)
and not monomers (i.e., with the dye front). The α-synuclein
species observed following the multimer-PAGE, once optimized,
were in general agreement with the previously reported α-
synuclein multimers,2,5−7 and distinct from those produced by
diﬀusion mediated protein cross-linking.
Future studies are needed to explore the applicability of the
multimer-PAGE technique. Studies that may be fruitful should
focus on the possible heterogeneity (e.g., diﬀerences in protein
folding, post-translational modiﬁcation etc.) of the observed α-
synuclein multimers and how this may confer/abolish stability.
Liquid chromatography−mass spectrometry (LC−MS) would
be particularly useful in identifying possible heterogeneity post-
translational modiﬁcations between multimers; although mass
adjustments to account for the cross-linker would need to be
applied, as has been done numerous reports.25 LC−MSmay also
allow for the identiﬁcation of the speciﬁc lipid(s) interacting with
α-synuclein.26 It is also important to further validate multimer-
PAGE across several PD models to determine its usefulness in
describing the pathology of the disease.
Multimer-PAGE provides several unique advantages over in-
solution cross-linking or native-PAGE alone. Kinetics of the
chemical cross-linking reaction could be controlled precisely
making the comparison between many samples easily reprodu-
cible. The preseparation of proteins appeared to reduce diﬀusion
based cross-linking, probably because the movement of
complexes in the sample was restricted to the immediate vicinity
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of their position in the polyacrylamide gel, making chance
interactions with other proteins unlikely. Multimer-PAGE
seemed useful in detecting stable protein complexes other that
α-synuclein multimers. In this regard, multimer-PAGE may be a
particularly valuable supplemental technique for BN-PAGE, to
verify true protein complexes, as protein mobility on BN-PAGE
alone clearly is not suﬃcient.19 For example, multimer-PAGE
detected parkin as a monomer (50 kDa) in contrast to a previous
report that found parkin to be exclusively a tetramer, based on
BN-PAGE experiments.27 Multimer-PAGE format also allows
the simultaneous comparison of many biological samples, so that
relative protein complex abundance can be compared on a single
blot. Although not reported here, gels could also be incubated
with solutions containing experimental molecules to assess their
inﬂuence on complex stability.
Lipid−protein cross-linking could occur between α-synuclein
and phosphatidalserine or phosphatidylethanolamine. This
interpretation of the data has the advantage of explaining the
seemingly anomalous behavior of α-synuclein following sample
dilution prior to chemical cross-linking (seen in Figure 3B). DSP
treatment enhances α-synuclein detection on PVDF membranes
as described previously.28 The enhancement is lost upon sample
dilution. Because we observed that α-synuclein association with
endogenous lipids was sensitive to dilution, it could be that upon
dilution α-synuclein disassociates from endogenous lipids,
reverting to an unstable intrinsically dynamic protein in solution.
Cross-linking of free α-synuclein would then likely form a more
compact structure as adjacent lysine residues of α-synuclein
cross-link to each other. In contrast, if lipid−protein cross-linking
occurred between α-synuclein and several phospholipids, α-
synuclein would not only have a larger molecular radius but
would presumably be more hydrophobic, allowing for enhanced
PVDF binding. Data provided here is insuﬃcient to conclusively
aﬃrm or reject this interpretation and future studies should aim
to address this potentially important molecular behavior of
soluble α-synuclein.
Overall, multimer-page is a useful technique to study protein
complexes in great detail. Multimer-PAGE was used successfully
to describe and compare soluble α-synuclein multimers across
complex biological samples. Future studies should focus on the
applicability of this technique to studying PD pathogenesis.
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